why is it so???

Firstly , let me preface my comments with this - I am a long term holder with great faith in the team at prima. However , when watching the great reaction to novogen ( NRT) and their trial results over the last few days , I can't help but feel a bit miffed and confused. Their results are positive yes , but much less further down the path than Primas with Cvac and yet the SP has taken off! We had great results announced in October and the impact on the SP was underwhelming to say the least. I understand the market is a fickle place , perhaps I am not comparing apples to apples??,, should we prepare ourselves that this is the way it will be for a long long time yet. I don't know. Sometimes I do wonder ..can anyone shed some light on this?. Or is it simply that this is how it is. Thanks